ATE353877T1 - Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern - Google Patents

Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern

Info

Publication number
ATE353877T1
ATE353877T1 AT04717645T AT04717645T ATE353877T1 AT E353877 T1 ATE353877 T1 AT E353877T1 AT 04717645 T AT04717645 T AT 04717645T AT 04717645 T AT04717645 T AT 04717645T AT E353877 T1 ATE353877 T1 AT E353877T1
Authority
AT
Austria
Prior art keywords
pyridinyl
keto esters
pyrimidinyl
monoifluorinated
beta
Prior art date
Application number
AT04717645T
Other languages
German (de)
English (en)
Inventor
Jonathan Frost
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of ATE353877T1 publication Critical patent/ATE353877T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT04717645T 2003-03-07 2004-03-05 Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern ATE353877T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03290568A EP1454900A1 (en) 2003-03-07 2003-03-07 Process for the preparation of pyridinyl and pyrimidinyl mono-fluorinated beta keto-esters

Publications (1)

Publication Number Publication Date
ATE353877T1 true ATE353877T1 (de) 2007-03-15

Family

ID=32799102

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04717645T ATE353877T1 (de) 2003-03-07 2004-03-05 Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern

Country Status (9)

Country Link
US (1) US7135569B2 (https=)
EP (2) EP1454900A1 (https=)
JP (1) JP4805809B2 (https=)
CN (1) CN100398518C (https=)
AT (1) ATE353877T1 (https=)
DE (1) DE602004004767T2 (https=)
ES (1) ES2281786T3 (https=)
RU (1) RU2330844C2 (https=)
WO (1) WO2004078725A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU556140A1 (ru) * 1975-01-06 1977-04-30 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвийской Сср (1-Оксоинданил-2)-пиридины в качестве промежуточных продуктов дл синтеза биологически активных соединений с способ их получени
US6300511B1 (en) * 1997-07-18 2001-10-09 F2 Chemicals Limited Catalyzed fluorination of carbonyl compounds
US6455728B1 (en) * 1999-11-01 2002-09-24 Air Products And Chemicals, Inc. Direct fluorination process for preparing high purity 2-fluoro-1,3-dicarbonyl compounds using oxygen as a radical scavenger
EP1295885A1 (en) * 2001-09-21 2003-03-26 Sanofi-Synthelabo Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
AU2002350487C1 (en) * 2001-09-21 2008-10-02 Mitsubishi Pharma Corporation Substituted 2-pyridinyl-6,7,8,9- tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
EP1295884A1 (en) * 2001-09-21 2003-03-26 Sanofi-Synthelabo 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]Pyrimidin-4-one and 7-Pyrimidinyl-2,3-Dihydroimidazo[1,2-a]Pyrimidin-5(1H)one derivatives

Also Published As

Publication number Publication date
ES2281786T3 (es) 2007-10-01
JP2006519815A (ja) 2006-08-31
EP1454900A1 (en) 2004-09-08
DE602004004767D1 (de) 2007-03-29
US7135569B2 (en) 2006-11-14
EP1603876A1 (en) 2005-12-14
RU2005131007A (ru) 2006-06-27
CN1771229A (zh) 2006-05-10
EP1603876B1 (en) 2007-02-14
RU2330844C2 (ru) 2008-08-10
CN100398518C (zh) 2008-07-02
JP4805809B2 (ja) 2011-11-02
US20060058526A1 (en) 2006-03-16
WO2004078725A1 (en) 2004-09-16
DE602004004767T2 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
ATE371657T1 (de) Verfahren zur herstellung kondensierter oxazinone aus einer aromatischen ortho-aminocarbonsäure und einer carbonsäure in gegenwart eines sulfonylchlorids und pyridin
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
ATE422200T1 (de) Verfahren zur herstellung substituierter nikotinsäureester
SE9904850D0 (sv) Novel process and intermediates
MA29464B1 (fr) Methode de preparation d'acides 1,6-dihydro-6-oxo-4-pyrimidinecarboxyliques eventuellement 2-substitues
ATE544744T1 (de) Verfahren zur herstellung von benzoesaure derivaten
WO2008126943A3 (en) Method for manufacturing neuraminic acid derivatives
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE353877T1 (de) Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern
ATE517096T1 (de) Verfahren zur herstellung von aminopyrimidinen
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE255103T1 (de) Verfahren zur herstellung von pyridinmethanol- verbindungen
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
DE60122539D1 (de) Neues verfahren zur herstellung einer chinolon-carbonsäure
MEP1708A (xx) Postupak proizvodnje thip-a
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
ATE465999T1 (de) Verfahren zur herstellung substituierter pyrimidine
ATE346845T1 (de) Ein verfahren zur herstellung substituierter alkylamin-derivate
DE60004054D1 (de) Neue verfahren zur herstellung von 17beta-hydroxy-17alpha-methyl-2-oxa-5alpha-androstane-3-on
DE60336739D1 (de) Verfahren zur herstellung eines 2-substituierten pyridinderivats
AU2003213386A1 (en) Process for production of optically active compounds
ATE260264T1 (de) Verfahren zur herstellung von oxazol-derivaten
EP1930331A4 (en) PROCESS FOR PREPARING IMIDAZO [1,2-b] PYRIDAZIN COMPOUNDS
RU2014117205A (ru) Способ получения производных 3,4-дигидроизохинолина и промежуточные соединения, полученные при его осуществлении

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties